,
Freyr assisted a US-based biopharmaceutical company in compilation, evaluation, and submission as an end-to-end Regulatory Operations for its CRL extension to the United States Food and Drug Administration (US FDA).
Freyr guided the client, and the client, in return, received optimized Regulatory support in line with updated guidelines.
Download the proven case to learn how Freyr’s RA team assisted the customer with this project.
Fill the form below to download the Case Study
